Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps

Maturitas

Volumn 59, Issue 3, 2008, Pages 268-274

  Erdemoglu, Evrim ^a   Güney, Mehmet ^a   Karahan, Nermin ^a   Mungan, Tamer ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cyclooxygenase; Endometrial polyp; Immunohistochemical analysis; Matrix metalloproteinase; Menopause

Indexed keywords

CYCLOOXYGENASE 2; ESTROGEN; GELATINASE A; GELATINASE B; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIUM POLYP; EPITHELIUM CELL; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN EXPRESSION; STROMA CELL;

CYCLOOXYGENASE 2; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; POLYPS; POSTMENOPAUSE; PREMENOPAUSE;

EID: 43049121273     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.02.007     Document Type: Article

References (20)

1. Taylor L.J., Jackson T.L., Reid J.G., and Duffy S.R.G. The differential expression of estrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 110 9 (2003) 794-798
2. McGurgan P., O'Donovan P., and Duffy S. How should we manage endometrial polyps? The yearbook of obstetrics and gynaecology. RCOG Press 10 (2002) 348-357
3. Inceboz U.S., Nese N., Uyar Y., Ozcakir H.T., Kurtul O., and Baytur Y.B. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps. Gynecol Obstet Invest 61 1 (2006) 24-28
4. Lurlaro M., Loverro G., Vacca A., Cormio G., Ribatti D., and Minischetti M. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest 29 9 (1999) 793-801
5. Li W., Xu R.J., Jiang L.H., Shi J., Long X., and Fan B. Expression of cyclooxygenase-2 and inducible nitric oxide synthase correlates with tumor angiogenesis in endometrial carcinoma. Med Oncol 22 1 (2005) 63-70
6. Graesslin O., Cortez A., Uzan C., Birembaut P., Quereux C., and Darai E. Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions. Int J Gynecol Cancer 16 5 (2006) 1911-1917
7. Goffin F., Munaut C., Frankenne F., Per rier D'Hauterive S., Beliard A., and Fridman V. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 69 3 (2003) 976-984
8. Liou J.Y., Ghelani D., Yeh S., and Wu K.K. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3{varepsilon}. Cancer Res 1 67(7) (2007) 3185-3191
9. Sabichi A.L., and Lippman S.M. COX-2 inhibitors and other non steroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol 31 (2004) 36-44
10. Maia Jr. H., Maltez A., Studard E., Zausner B., Athayde C., and Coutinho E. Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium. Gynecol Endocrinol 21 1 (2005) 57-61
11. Li W., Xu R.J., Zhang H.H., and Jiang L.H. Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer 16 4 (2006) 1673-1678
12. Aglund K., Marita R., Puistola U., et al. A and B (MMP-2 and MMP-9) in endometrial cancer - MMP-9 correlates to the upgrade and the stage. Gynecol Oncol 94 (2004) 699-704
13. Maia Jr. H., Correia T., Freitas L.A., Athayde C., and Coutinho E. Cyclooxygenase-2 expression in endometrial polyps during menopause. Gynecol Endocrinol 21 6 (2005) 336-339
14. Taylor L.J., Jackson T.L., Reid J.G., and Duffy S.R. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 110 9 (2003) 794-798
15. McGurgan P., Taylor L.J., Duffy S.R., and O'Donovan PJ. An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to HRT. Maturitas 20 53(4) (2006) 454-461
16. Galant C., Berliere M., Dubois D., Verougstraete J.C., Charles A., and Lemoine P. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding. Am J Pathol 165 1 (2004) 83-94
17. Freitas S., Meduri G., Le Nestour E., Bausero P., and Perrot-Applanat M. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 61 4 (1999) 1070-1082
18. Rodgers W.H., Matrisian L.M., Giudice L.C., et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94 (1994) 946-953
19. Maia H., Correia T., Freitas L., Athayde C., and Coutinho E.M. Cyclooxygenase-2 expression in the endometrium and its relationship to bleeding in users of continuous oral contraceptives. Gynecol Endocrinol 22 2 (2006) 96-100
20. McGurgan P., Taylor L.J., Duffy S.R., and O'Donovan P.J. Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre- and post-menopausal women. Maturitas 54 3 (2006) 277-284